Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802034 · ClinicalTrials.gov registry record
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
A clinical trial of Kidney Diseases and Lupus Nephritis, sponsored by The Rogosin Institute.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT01802034: Recruiting study of Kidney Diseases and Lupus Nephritis, sponsored by The Rogosin Institute.
NCT01802034 is a study of Kidney Diseases and Lupus Nephritis that is actively recruiting participants, run by The Rogosin Institute. The registered enrollment target is 2,000 participants, above the 1,733-participant average among 38 other Kidney Diseases trials with a reported enrollment target (15% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01802034, a study of Kidney Diseases and Lupus Nephritis, is actively recruiting participants, sponsored by The Rogosin Institute.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.
Conditions Studied
Study Locations (1)
New York
- The Rogosin Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2013-02 |
| Est. Completion | 2028-08 |
What NCT01802034 shows while recruiting
NCT01802034 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,733-participant average among 38 other Kidney Diseases trials with a reported enrollment target (15% higher).
The record links to 5 conditions, with Kidney Diseases appearing as the primary indexed condition, and to 0 interventions.
NCT01802034 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01802034 about?
NCT01802034 is a clinical study titled "Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)". A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory/autoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to s...
What is the current status of trial NCT01802034?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2013-02. Estimated completion is 2028-08.
What conditions does trial NCT01802034 study?
This clinical trial studies the following conditions: Kidney Diseases, Lupus Nephritis, Kidney Failure, Chronic, Diabetic Nephropathy, Glomerulonephritis, IGA.
Who is sponsoring clinical trial NCT01802034?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01802034 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01802034's enrollment target sits among peer trials
2,000 4th of 38 higher than 35 of 38 other Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collaborative Learning to Achieve Refined Interventions for Emory: Kidney Disease
RECRUITING · NA
-
Rutgers University Study of the Genetics of Kidney Disease
RECRUITING
-
Supporting VETerans With Kidney Disease Through Food As Medicine
RECRUITING · NA
-
Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RECRUITING · Phase 3
-
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
RECRUITING · NA
-
Dietary Intervention to Improve Kidney Transplant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia